{
    "2018-11-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Celgene & Bluebird's CAR T Therapy Study Completes Enrollment",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Bluebird",
                        "CAR T",
                        "therapy",
                        "study",
                        "enrollment"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novartis (NVS) Receives EC Approval for Neulasta Biosimilar",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EC",
                        "Approval",
                        "Neulasta",
                        "Biosimilar"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "Novartis' Biosimilar to Amgen's Neulasta Approved in Europe",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Biosimilar",
                        "Amgen",
                        "Neulasta",
                        "Europe",
                        "Approved"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Glaxo's Horlicks Sale Bid Heats Up, Nestle, Unilever Close In",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Horlicks",
                        "Sale",
                        "Bid",
                        "Nestle",
                        "Unilever"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods",
                        "food and beverage"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Novartis joins rush of science companies moving to White City",
                "features": {
                    "keywords": [
                        "Novartis",
                        "science",
                        "companies",
                        "White City",
                        "moving"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}